Because of the huge loss of 6 percent since early this year, the share is one of the worst shares of the pharmaceutical sector. The average stock of the pharmaceutical sector yielded the this year a profit of 26 percent. Other underperforming shares are Hubei Minkang Pharmaceutical, Wize Pharma Inc and Oxis International .
For this year the company, based inParijs revenue will be around 36,76 billion euros. This is according to the average of the analysts' estimates. This is slightly lower than 2019's revenue of 37,63 billion euros.
The analysts expect for 2020 a net profit of 7,34 billion euros. The majority of the analysts expects for this year a profit per share of 5,81 euros. Based on this the price/earnings-ratio is 14,46.
Based on the current number of shares Sanofi-Aventis 's market capitalization equals 104,67 billion euros. The Sanofi-Aventis stock was the past 12 months quite unstable. Since last December the stock is 4 percent higher. This year the stock price moved between 68 and 96 euro.
Click here for dividend Sanofi-Aventis. At 16.57 the stock trades 1,17 percent lower at 84,04 euros.
Analist.nl Nieuwsdienst: +31 084-0032-842
Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. Analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.